Although NK cell infiltration is limited in HR+ tumors, HR+ breast cancer cell lines are more susceptible to IL-2 stimulated NK cell lysis than are TNBC or HER2+ cell lines (106–108), indicating that potential strategies to target HR+ tumors may include adoptive transfer of exogenously stimulated or genetically altered NK cells. Here, ERBB2 is linked to breast carcinoma.